文献速递多重用药老年综合评估

潜在不适当用药处方与美国老年人健康相关生活质量的关联

Association between potentially inappropriate medications prescription and health-related quality of life among US older adults.
PubMed 文献 · J Am Geriatr Soc · 2024-05-10

该回顾性研究利用2011-2015年美国医疗支出面板调查(MEPS)数据,纳入65岁及以上社区居住老年人,采用2019年美国老年医学会Beers标准定义潜在不适当用药(PIM)暴露,以SF-12量表的躯体成分总结(PCS)和心理成分总结(MCS)评估健康相关生活质量(HRQoL)。结果显示,PIM暴露与各年龄组较差的PCS评分相关,并与65-74岁及85岁及以上人群较差的MCS评分相关,提示PIM暴露与较差HRQoL相关。

要点

  • PIM暴露与65岁及以上各年龄组较差的PCS评分均相关。
  • PIM暴露与65-74岁和85岁及以上人群较差的MCS评分相关。
  • 需进一步研究评估减少PIM处方能否改善患者HRQoL。

核心结论

  • PIM暴露与美国老年人较差的健康相关生活质量相关。
  • 需进一步研究评估减少PIM处方的干预是否有助于改善患者HRQoL。

研究设计与样本

  • 回顾性研究,利用2011-2015年医疗支出面板调查(MEPS)数据。
  • 纳入社区居住的65岁及以上美国成年人。
  • 采用基于2019年美国老年医学会Beers标准®的可操作定义界定研究期间PIM暴露。
  • 以SF-12量表的PCS和MCS测量HRQoL,构建调查加权线性回归模型分析关联,并按65-74、75-84、≥85岁三个年龄队列分层。

主要发现

  • 未调整分析显示PIM暴露组PCS和MCS评分均较差(所有p < 0.001)。
  • PIM暴露与65-74岁人群较差的PCS评分相关(调整回归系数 = -1.60 [95% CI = -2.27, -0.93; p < 0.001])。
  • PIM暴露与75-84岁人群较差的PCS评分相关(调整回归系数 = -1.49 [95% CI = -2.45, -0.53; p = 0.003])。
  • PIM暴露与85岁及以上人群较差的PCS评分相关(调整回归系数 = -1.65 [95% CI = -3.03, -0.27; p = 0.02])。
  • PIM暴露与65-74岁人群较差的MCS评分相关(调整回归系数 = -0.69 [95% CI = -1.16, -0.22; p = 0.004]),与85岁及以上人群较差的MCS评分相关(调整回归系数 = -2.01 [95% CI = -3.25, -0.78; p = 0.002])。

关键数值与推荐

  • PIM定义采用基于2019年美国老年医学会Beers标准®的可操作定义。
  • HRQoL采用SF-12量表的PCS和MCS评分测量。
  • 年龄分层为65-74岁、75-84岁和85岁及以上三个队列。

临床怎么用

  • 在老年综合评估中应关注PIM暴露,并将其视为与较差HRQoL相关的可干预因素。
  • 对65岁及以上社区老年人处方时应依据Beers标准审核PIM,尤其关注躯体健康相关生活质量。
  • 对85岁及以上高龄老年人,PIM暴露与心理成分评分较差相关更明显,处方审核时需同时关注心理维度。

局限性

  • 原文未报告研究局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Potentially inappropriate medications (PIMs) are associated with worse health outcomes among older adults. Our objective was to examine the association between PIM prescription and health-related quality of life (HRQoL) among older adults in the United States using nationally representative data. METHODS: This was a retrospective study utilizing 2011-2015 Medical Expenditure Panel Survey (MEPS) data. Community dwelling US adults aged 65 years or older were included. A qualified definition operationalized from the 2019 American Geriatrics Society Beers Criteria® was used to define exposure to PIMs during the study period. The Physical Component Summary (PCS) and Mental Component Summary (MCS) of the Medical Outcomes Study 12-Item Short Form Health Survey (SF-12) were used to measure HRQoL. Survey-weighted linear regression models were constructed to investigate the association between PIM exposure and participants' PCS and MCS scores. Analyses were stratified across three age cohorts (65-74, 75-85, and ≥85 years). RESULTS: Unadjusted analysis showed poorer scores in the PIM exposed group for both PCS and MCS (all p < 0.001). PIM exposure was associated with poorer PCS scores across all age groups with those aged 65-74 years (adjusted regression coefficient = -1.60 [95% CI = -2.27, -0.93; p < 0.001]), those 75-84 years (adjusted regression coefficient: -1.49 [95% CI = -2.45, -0.53; p = 0.003]), and those 85 years and older (adjusted regression coefficient = -1.65 [95% CI = -3.03, -0.27; p = 0.02]). PIM exposure was also associated with poorer MCS scores in participants aged 65-74 years (adjusted regression coefficient = -0.69 [95% CI = -1.16, -0.22; p = 0.004]) and 85 years and older (adjusted regression coefficient = -2.01 [95% CI = -3.25, -0.78; p = 0.002]). CONCLUSIONS: Our results suggest that patients' exposure to PIMs is associated with poorer HRQoL. Further work is needed to assess whether interventions to deprescribe PIMs may help to improve patients' HRQoL.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Clark CM, Guan J, Patel AR, et al. Association between potentially inappropriate medications prescription and health-related quality of life among US older adults. J Am Geriatr Soc. 2024. PMID: 38725422. doi:10.1111/jgs.18957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。